These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 13084042)

  • 41. Well-differentiated serous neoplasms of the ovary.
    Longacre TA; Kempson RL; Hendrickson MR
    Pathology (Phila); 1993; 1(2):255-306. PubMed ID: 9420921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Early diagnosis of malignant tumors of the the ovary using ultrasound].
    Todorović G; Visnjevac V; Pasić R
    Med Arh; 1990; 44(1):31-3. PubMed ID: 2093774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors].
    Cai Y; Shao SL; Wang QH; Yan LJ; Wang XY; Wang LX
    Ai Zheng; 2007 Nov; 26(11):1188-93. PubMed ID: 17991316
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bilateral micropapillary serous carcinoma of the ovary: a case report.
    Gupta R; Singh S; Nigam S
    Arch Gynecol Obstet; 2007 May; 275(5):401-4. PubMed ID: 17031658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
    Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
    Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Serous micropapillary invasive carcinoma. Case report on both ovaries].
    Espinosa de los Monteros Franco VA; Padilla Rodríguez AL
    Ginecol Obstet Mex; 2007 Nov; 75(11):682-6. PubMed ID: 18697443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
    Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY
    Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
    Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
    Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
    Schmandt RE; Broaddus R; Lu KH; Shvartsman H; Thornton A; Malpica A; Sun C; Bodurka DC; Gershenson DM
    Cancer; 2003 Aug; 98(4):758-64. PubMed ID: 12910520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of malignant neoplasms of the ovaries].
    VOSKRESENSKII NA
    Akush Ginekol (Mosk); 1954; 2():38-42. PubMed ID: 13148071
    [No Abstract]   [Full Text] [Related]  

  • 53. Localization of the stem cell markers LGR5 and Nanog in the normal and the cancerous human ovary and their inter-relationship.
    Amsterdam A; Raanan C; Schreiber L; Freyhan O; Schechtman L; Givol D
    Acta Histochem; 2013 May; 115(4):330-8. PubMed ID: 23092806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors.
    Fu YS; Ro J; Reagan JW; Hall TL; Berek J
    Obstet Gynecol; 1986 Apr; 67(4):478-82. PubMed ID: 3960418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human ovarian tumors express gamma-glutamyl transpeptidase.
    Hanigan MH; Frierson HF; Brown JE; Lovell MA; Taylor PT
    Cancer Res; 1994 Jan; 54(1):286-90. PubMed ID: 7903206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues.
    Brandenberger AW; Tee MK; Jaffe RB
    J Clin Endocrinol Metab; 1998 Mar; 83(3):1025-8. PubMed ID: 9506768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study.
    Barnhill DR; Kurman RJ; Brady MF; Omura GA; Yordan E; Given FT; Kucera PR; Roman LD
    J Clin Oncol; 1995 Nov; 13(11):2752-6. PubMed ID: 7595734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms.
    Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM
    Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin.
    Skubitz AP; Bast RC; Wayner EA; Letourneau PC; Wilke MS
    Am J Pathol; 1996 May; 148(5):1445-61. PubMed ID: 8623916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.